Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FY5QX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,666
Award facts
- Contract value 100% obligated
- $44,666.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,666.45 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This contract is classified as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of June 3, 2025. Eliquis is a widely prescribed anticoagulant medication used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, as well as for treatment and prevention of deep vein thrombosis and pulmonary embolism.
This delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the Defense Logistics Agency's Medical Supply Chain. The award is issued under the company's parent Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's federal contracting activity demonstrates its critical role as a major pharmaceutical distributor supplying brand-name and generic medications to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FY5QX?
SPE2DB25FY5QX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FY5QX worth?
The government has obligated $44,666 on SPE2DB25FY5QX.
Is contract SPE2DB25FY5QX an order under another contract?
Yes. SPE2DB25FY5QX is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY5QX competed?
The extent of competition for SPE2DB25FY5QX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award